Overview

Study on Supplement of Intravenous Ferric Derisomaltose to Prevent Anemia and Improve the Quality of Life in Obese Patients With Iron Deficiency.

Status:
RECRUITING
Trial end date:
2027-03-30
Target enrollment:
Participant gender:
Summary
This study aimed to explore the effects of preoperative intravenous isomaltose iron supplementation versus placebo on postoperative Hb improvement, prevention of postoperative anemia, and improvement in quality of life in patients undergoing bariatric surgery.
Phase:
NA
Details
Lead Sponsor:
China-Japan Friendship Hospital
Treatments:
iron isomaltoside 1000